Home > News

News & Events

Venebio Chief Medical Officer Presents at 2011 ESPACOMP Symposium
RICHMOND, VA, December 9, 2011 – Barbara K. Zedler, MD, Chief Medical Officer of Venebio Group, LLC was an invited presenter at the 2011 European Symposium on Patient Adherence, Compliance and Persistence (ESPACOMP) held in Utrecht, The Netherlands, November 18 and 19. More...

Venebio leads medication adherence study for MeadWestvaco Healthcare
RICHMOND, VA, August 2, 2011 – Venebio Group, LLC recently completed a study for the Healthcare Division of MeadWestvaco Corporation (NYSE: MWV) to evaluate the real-world effectiveness of MWV’s Shellpak® brand reminder packaging in improving long-term medication adherence. More...

Venebio Chief Scientific Officer presents 2010 Portfolio of Scientific Activities
RICHMOND, Virginia, February 1, 2011 – At the 2010 Venebio Annual Meeting, Andrew Joyce, PhD, Venebio’s Chief Science Officer, summarized the company’s 2010 portfolio of external scientific and academic accomplishments. More...

Venebio announces record growth in 2010, strong outlook for 2011
RICHMOND, Virginia, January 3, 2011 – Venebio Group, LLC today announced record revenue levels and revenue growth for the full year ending December 31, 2010. More...

Venebio Group announces new Chief Operating Officer
RICHMOND, Virginia, September 13, 2010 – Venebio Group, LLC announced the appointment of Mr. Duff Young as its new Chief Operating Officer (COO) effective September 13, 2010. More...

Venebio Group, LLC announces record growth in the first quarter of 2010
RICHMOND, Virginia, April 1, 2010 – Venebio Group, LLC today announced record revenue levels and revenue growth for the first quarter ending March 31, 2010. Despite tumultuous economic conditions and continued reductions in research and development spending in the life sciences industry, Venebio’s revenue for the first quarter alone exceeded the prior full year revenue by 60%. More...

Venebio to compile scientific evidence regarding medication adherence for MeadWestvaco Corp.
RICHMOND, Virginia – February 10, 2010 ‑ Venebio Group, LLC (Venebio) today announced that it has entered into a consulting agreement with MeadWestvaco Corp. (MWV). MWV has engaged Venebio in the compilation of scientific evidence regarding issues associated with “medication adherence”. More...

Venebio named a Greater Richmond Company to Watch for 2010
RICHMOND, Virginia – October 29, 2009 ‑ Venebio was selected as one of eight “Greater Richmond’s Companies to Watch (GRCTW)” for 2010. The announcement was made during the Venture Forum’s fifth annual event on October 29, 2009. The Venture Forum is a Richmond-area networking group for investment professionals and entrepreneurs and the award is presented each year to companies that "have built solid foundations for success, job creation and [made] major contributions to the area's economic vitality." More...

Venebio selects interns for CBEF-sponsored Summer Internship Program
RICHMOND, Virginia – August 1, 2009 ‑ Venebio Group, LLC announces the selection of two summer business interns; Mr. Nima Jarvandi, a second year MBA student in the Virginia Commonwealth University (VCU) School of Business, and Mr. Michael D’Alessandro, a senior in the VCU undergraduate business program. The internships will involve hands-on experience in marketing, business development, and finance functions at Venebio. More...

Venebio launches website
RICHMOND, Virginia – April 24, 2009 ‑ Venebio Group, LLC, a global network of expert scientists providing custom solutions to the life sciences industry, announces the launch of its new website, www.venebio.com. The site offers a streamlined, easy-to-navigate introduction to Venebio’s extensive core services and its people. More...

Venebio signs teaming agreement with Solveritas, LLC
RICHMOND, Virginia – March 31, 2009 ‑ Venebio Group, LLC, announces the signing of a teaming agreement with Solveritas, LLC under which the companies will collaborate on the commercialization of proprietary technologies developed by Solveritas. More...

Venebio Group, LLC Signs Biomarker Consulting Agreement with LineaGen, Inc.
RICHMOND, Virginia – March 1, 2009 ‑ Venebio Group, LLC, today announced the execution of a strategic partnership with LineaGen, Inc. (www.lineagen.com), a content-based biomarker discovery company in Salt Lake City, Utah. More...

Venebio joins Virginia BioTechnology Research Park
RICHMOND, Virginia - September 1, 2008 ‑ Venebio Group, LLC, a startup company that provides custom solutions to the life sciences industry, is now headquartered at the Virginia BioTechnology Research Park (VBRP) in downtown Richmond, in the heart of the East Coast pharmaceutical and biotechnology corridor. While Venebio is a virtual global network of scientific experts, this site will serve as its center of operations. The decision to locate at the VBRP was largely influenced by its proximity to the Medical College of Virginia campus of Virginia Commonwealth University and by the biosciences business incubator program offered by the Virginia Biosciences Development Center of the VBRP. The incubator provides business strategy and assistance, as well as business support to startup companies located in the research park. More...